|
| Gene name | Unigene ID | Gene symbol | Transcript level (fold over nonstimulated control) |
| 9.2s RNA | CL264 | 9.2s RNA + CL264 | Synergistic increase |
|
| CD69 molecule | Hs.208854 | CD69 | 2.4 | 6.1 | 64.2 | 7.6 |
| BCL2-related protein A1 | Hs.227817 | BCL2A1 | 2.7 | 22.2 | 96.6 | 3.9 |
| baculoviral IAP repeat containing 3 | Hs.127799 | BIRC3 | 1.2 | 6.4 | 25.6 | 3.4 |
| RALBP1 associated Eps domain containing 2 | Hs.186810 | REPS2 | 1.0 | 2.4 | 10.3 | 3.1 |
| Interferon, beta 1, fibroblast | Hs.93177 | IFNB1 | 1.6 | 1.9 | 10.8 | 3.1 |
| Suppressor of tumorigenicity 20 | Hs.729127 | ST20 | 1.3 | 4.8 | 18.5 | 3.0 |
| Chemokine (C-C motif) ligand 2 | Hs.303649 | CCL2 | 0.6 | 41.4 | 126.0 | 3.0 |
| CD44 molecule | Hs.502328 | CD44 | 1.5 | 4.3 | 17.5 | 3.0 |
| Early growth response 3 | Hs.534313 | EGR3 | 2.1 | 3.3 | 15.9 | 2.9 |
| Tubulin tyrosine ligase-like family | Hs.520554 | TTLL2 | 1.1 | 3.1 | 11.9 | 2.8 |
| Oligonucleotide/oligosaccharide-binding fold containing 2A | Hs.591610 | OBFC2A | 1.7 | 12.4 | 38.6 | 2.7 |
| Interleukin 6 (interferon, beta 2) | Hs.654458 | IL-6 | 0.9 | 4.9 | 14.7 | 2.6 |
| Nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, alpha | Hs.81328 | NFKBIA | 1.6 | 6.2 | 19.6 | 2.5 |
| MIR155 host gene (non-protein-coding) (MIR155HG), noncoding RNA. | N/A | MIR155HG | 1.5 | 1.9 | 8.1 | 2.4 |
| Chemokine (C-C motif) ligand 1 | Hs.72918 | CCL1 | 2.4 | 15.6 | 41.8 | 2.3 |
| RasGEF domain family, member 1B | Hs.591696 | RASGEF1B | 1.1 | 3.3 | 10.2 | 2.3 |
| CD70 molecule | Hs.501497 | CD70 | 1.4 | 6.1 | 16.5 | 2.2 |
| G protein-coupled receptor 183 | Hs.784 | GPR183 | 1.0 | 2.6 | 7.8 | 2.2 |
| ADAM metallopeptidase with thrombospondin type 1 motif, 10 | Hs.657508 | ADAMTS10 | 1.0 | 1.9 | 6.1 | 2.1 |
| ADAM metallopeptidase domain 19 | Hs.483944 | ADAM19 | 2.4 | 3.6 | 12.6 | 2.1 |
| FSHD region gene 2 family, member C | Hs.274541 | FRG2C | 0.8 | 1.1 | 4.1 | 2.1 |
| Interleukin 23, alpha subunit p19 | Hs.98309 | IL-23A | 1.6 | 7.8 | 19.4 | 2.1 |
| EF-hand calcium binding domain 3 | Hs.152670 | EFCAB3 | 1.0 | 1.3 | 4.8 | 2.1 |
| Neutrophil cytosolic factor 2 | Hs.587558 | NCF2 | 1.8 | 3.8 | 11.5 | 2.1 |
| Interleukin 1, beta | Hs.126256 | IL-1B | 1.0 | 7.3 | 17.0 | 2.1 |
| Nuclear receptor subfamily 4, group A, member 3 | Hs.279522 | NR4A3 | 1.4 | 3.1 | 9.4 | 2.1 |
| Tumor necrosis factor, alpha-induced protein 3 | Hs.211600 | TNFAIP3 | 1.5 | 3.5 | 10.2 | 2.1 |
| Regulator of G-protein signaling 1 | Hs.75256 | RGS1 | 1.7 | 3.5 | 10.7 | 2.0 |
| Serum/glucocorticoid regulated kinase 1 | Hs.510078 | SGK1 | 0.5 | 1.8 | 4.8 | 2.0 |
| v-rel reticuloendotheliosis viral oncogene homolog | Hs.631886 | REL | 1.1 | 2.4 | 6.7 | 2.0 |
| Immediate early response 3 | Hs.76095 | IER3 | 0.8 | 4.3 | 9.9 | 1.9 |
| Nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, zeta | Hs.319171 | NFKBIZ | 1.3 | 2.7 | 7.8 | 1.9 |
| Chemokine (C-C motif) ligand 4-like 2 | Hs.661942 | CCL4L2 | 2.0 | 21.0 | 43.9 | 1.9 |
| Interleukin 18 receptor 1 | Hs.469521 | IL-18R1 | 2.5 | 6.9 | 17.9 | 1.9 |
| Interleukin 8 (IL8) | Hs.624 | IL-8 | 1.8 | 2.4 | 7.9 | 1.9 |
| CASP8 and FADD-like apoptosis regulator | Hs.390736 | CFLAR | 1.5 | 2.2 | 6.8 | 1.9 |
| pim-2 oncogene | Hs.496096 | PIM2 | 0.8 | 3.0 | 7.1 | 1.8 |
| Spermidine/spermine N1-acetyltransferase 1 | Hs.28491 | SAT1 | 1.6 | 3.6 | 9.5 | 1.8 |
| Interleukin 4 induced 1 | Hs.574492 | IL-4I1 | 1.2 | 4.0 | 9.4 | 1.8 |
| Chemokine (C-X-C motif) ligand 10 | Hs.632586 | CXCL10 | 1.6 | 5.8 | 13.1 | 1.8 |
| Solute carrier family 29 (nucleoside transporters), member 2 | Hs.569017 | SLC29A2 | 1.4 | 3.4 | 8.6 | 1.8 |
| Long intergenic non-protein-coding RNA 173, noncoding RNA. | N/A | LINC00173 | 1.8 | 3.2 | 8.8 | 1.8 |
| Mitogen-activated protein kinase kinase kinase 8 | Hs.432453 | MAP3K8 | 1.1 | 4.1 | 9.1 | 1.8 |
| Signal transducer and activator of transcription 5A | Hs.437058 | STAT5A | 0.8 | 1.9 | 4.6 | 1.7 |
| ADP-ribosylation factor-like 5B | Hs.25362 | ARL5B | 1.5 | 3.1 | 7.9 | 1.7 |
| Ninjurin 1 | Hs.494457 | NINJ1 | 0.9 | 3.4 | 7.3 | 1.7 |
| Wingless-type MMTV integration site family, member 10A | Hs.121540 | WNT10A | 1.2 | 5.8 | 11.6 | 1.6 |
| B cell translocation gene 1, antiproliferative | Hs.255935 | BTG1 | 1.5 | 2.6 | 6.7 | 1.6 |
| Fascin homolog 1, actin-bundling protein (Strongylocentrotus purpuratus) | Hs.118400 | FSCN1 | 0.5 | 1.6 | 3.5 | 1.6 |
| CD83 molecule | Hs.595133 | CD83 | 1.7 | 5.2 | 11.4 | 1.6 |
| Platelet-derived growth factor alpha polypeptide | Hs.535898 | PDGFA | 1.4 | 2.3 | 6.1 | 1.6 |
| Transcription factor EC | Hs.125962 | TFEC | 0.6 | 3.1 | 6.1 | 1.6 |
| CD40 molecule, TNF receptor superfamily member 5 | Hs.472860 | CD40 | 1.0 | 4.1 | 8.4 | 1.6 |
| POU class 2 homeobox 2 | Hs.654420 | POU2F2 | 0.6 | 3.2 | 6.2 | 1.6 |
| Nuclear receptor coactivator 7 | Hs.171426 | NCOA7 | 1.6 | 2.7 | 6.8 | 1.6 |
| Zinc finger protein 36, C3H type-like 1 | Hs.85155 | ZFP36L1 | 1.3 | 2.0 | 5.1 | 1.6 |
| Solute carrier family 7, member 11 | Hs.390594 | SLC7A11 | 1.4 | 2.2 | 5.7 | 1.6 |
| FSHD region gene 2 | Hs.626907 | FRG2 | 1.1 | 1.3 | 3.7 | 1.5 |
| Homo sapiens microRNA miR-146 stem-loop | N/A | hsa-mir-146a | 1.1 | 3.7 | 7.3 | 1.5 |
| Homo sapiens microRNA miR-21 stem-loop | N/A | hsa-mir-21 | 1.6 | 1.7 | 5.1 | 1.5 |
| BTB (POZ) domain containing 19 | Hs.632400 | BTBD19 | 0.8 | 1.7 | 3.9 | 1.5 |
| ELOVL fatty acid elongase 6 | Hs.412939 | ELOVL6 | 1.1 | 1.7 | 4.2 | 1.5 |
|
